What is Cotellic used for?
Medically reviewed by Judith Stewart, BPharm. Last updated on Dec 16, 2020.
Official Answer
by Drugs.comCotellic (cobimetinib) is an orally administered kinase inhibitor used to treat advanced melanoma (skin cancer) in patients with an abnormal genetic marker known as a BRAF V600E or V600K.
Cotellic is used in combination with vemurafenib (Zelboraf).
BRAF and MEK are proteins in a cell signaling pathway that help control cell growth and survival. Vemurafenib is designed to inhibit some mutated forms of BRAF, and Cotellic is designed to inhibit some forms of MEK. When used in combination, Cotellic and vemurafenib are thought to reduce cancer cell growth longer than with vemurafenib alone.
Related Medical Questions
- How long does Opdivo prolong life and what’s its success rate?
- What is the success rate of Keytruda?
- Is Keytruda covered by Medicare / Medicaid?
- Pembrolizumab vs. nivolumab: how do they compare?
- How does pembrolizumab affect the immune system?
- How does pembrolizumab kill cancer cells?
- What type of cancer is pembrolizumab used for?
Drug Information
- Cotellic Information for Consumers
- Cotellic Information for Healthcare Professionals (includes dosage details)
- Side Effects of Cotellic (detailed)
Related Support Groups
- Cotellic
- Melanoma - Metastatic (11 questions, 27 members)
